Treatment of peritoneal metastases from gastric carcinoma
Patients with advanced gastric cancer and positive peritoneal cytology and/or peritoneal dissemination are deemed to be incurable and to hold dismal prognosis. So far, the only treatment option for these patients has been palliative systemic (chemo)therapy. However, for the last three decades, great...
Principais autores: | Polkowski Wojciech P., Rawicz-Pruszynski Karol, Mielko Jerzy, Geca Katarzyna, Skorzewska Magdalena, Cisel Bogumila |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Sciendo
2017-12-01
|
coleção: | Current Issues in Pharmacy and Medical Sciences |
Assuntos: | |
Acesso em linha: | https://doi.org/10.1515/cipms-2017-0032 |
Registros relacionados
-
Advances in surgery for peritoneal surface malignancies
por: Mielko Jerzy, et al.
Publicado em: (2017-12-01) -
Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
por: Skierucha Malgorzata, et al.
Publicado em: (2017-12-01) -
Diaphragmatic peritoneal metastases mimicking liver metastases
por: Noiret Barbara, et al.
Publicado em: (2021-08-01) -
Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
por: Simkens GA, et al.
Publicado em: (2017-06-01) -
Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
por: Özgül Düzgün, et al.
Publicado em: (2019-09-01)